Cellular trafficking and cytotoxicity of anti-CD19-targeted liposomal doxorubicin in B lymphoma cells

Journal of Liposome Research

Volumn 9, Issue 2, 1999, Pages 199-228

  Lopes De Menezes, Daniel E ^a   Kirchmeier, Marc J ^a   Gagne, Jean Francois ^a   Pilarski, Linda M ^b   Allen, Theresa M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

Author keywords

B cell lymphoma; CD19; Liposomal doxorubicin

Indexed keywords

CATION EXCHANGE RESIN; CD19 ANTIGEN; CHOLESTEROL; CYTOTOXIC AGENT; DISTEAROYLPHOSPHATIDYLETHANOLAMINE; DOXORUBICIN; IMMUNOLIPOSOME; LIPID; LIPOSOME; MACROGOL; MONOCLONAL ANTIBODY; PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG RELEASE; DRUG TARGETING; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERNALIZATION; LYMPHOMA CELL LINE; LYSOSOME; PRIORITY JOURNAL;

EID: 0033043410     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.3109/08982109909024786     Document Type: Article

References (86)

1. Lopes de Menezes, D.E., Pilarski, L.M., and Allen, T.M. 1998. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. Cancer Res 58:3320-3330.
2. Allen, T.M., Ahmad, I., Lopes de Menezes, D.E., and Moase, E.H. 1995. Immunoliposome-mediated targeting of anti-cancer drugs in vivo. Biochem Soc Trans 23: 1073-1079.
3. Trail, P.A., Willner, D., Lasch, S.J., Henderson, A.J., Hofstead, S., Casazza, A.M., Firestone, R.A., Hellstrom, I., and Hellstrom, K.E. 1993. Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates. Science 261:212-215.
4. Tyle, P. and Ram, B.P. 1990. Monoclonal antibodies, immmunoconjugates, and liposomes as targeted therapeutic systems. Targeted Diagn Ther 3:3-22.
5. Crommelin, D.J.A., Scherphof, G., and Storm, G. 1995. Active targeting with particulate carrier systems in the blood compartment. Adv Drug Del Rev 17:49-60.
6. Saltzman, W.M. 1993. Antibodies for treating and preventing diseases: the potential role of polymeric controlled release. Crit. Rev. Therap. Drug Carrier Systems 10: 111-142.
7. Allen, T.M. 1994. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv Drug Del Rev 13: 285-309.
8. Woodle, M.C. and Storm, G. Long-Circulating Liposomes: Old Drugs, New Therapeutics Landes Bioscience, Georgetown, TX. 1998.
9. Allen, T.M., Hansen, C.B., and Stuart, D.D. Targeted sterically stabilized liposomal drug delivery. In Medical Applications of Liposomes. D.D. Lasic and D. Papahadjopoulos (eds.), pp. 297-323, Elsevier Science Publishers, Amsterdam. 1998.
10. HER2immunoliposomes for cancer therapy. Proc Natl Acad Sci USA. 92:1327-1331
11. Torchilin, V.P. and Klibanov, A.L. 1993. Coupling of ligands with liposome membranes. Drug Target Del. 2:227-238.
12. Ahmad, I. and Allen, T.M. 1992. Antibody-mediated specific binding and cytotoxicity of liposome-entrapped doxorubicin to lung cancer cells in vitro. Cancer Res. 52: 4817-4820
13. Torchilin, V.P., Klibanov, A.L., Huang, L., O'Donnell, S., Nossiff, N.D., and Khaw, B.A. 1992. Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium. FASEB J. 6:2716-2719.
14. Nassander, U.K., Steerenberg, P.A., Poppe, H., Storm, G., Poels, L.G., de Jong, W.H., and Crommelin, D.J.A. 1992. In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice. Cancer Res. 52:646-653.
15. Maruyama, K., Takizawa, T., Yuda, T., Kennel, S.J., Huang, L., and Iwatsuru, M. 1995. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol) conjugated at their distal terminals to monoclonal antibodies. Biochim Biophys Acta 1234:74-80.
16. Lee, R.J. and Low, P.S. 1995. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim Biophys Acta 1233:134-144.
17. Pagano, R.E. and Weinstein, J.N. Interactions of liposomes with mammalian cells. 1978. Ann Rev Biophys Bioeng. 7:435-468.
18. Poste, G. The interaction of lipid vesicles (liposomes) with cultured cells and their use as carriers for drugs and macromolecules. In Liposomes in Biological Systems. G. Gregoriadis and H. C. Allison (eds.), pp. 101-151, J. Wiley & Sons, Chichester. 1980.
19. Allen, T.M., Newman, M.S., Woodle, M.C., Mayhew, E., and Uster, P.S. 1995. Pharmacokinetics and anti-tumor activity of vincristine encapsulated in sterically stabilized liposomes. Int J Cancer. 62:199-204.
20. Lim, H.J., Masin, D., Madden, T.D., and Bally, M.B. 1997. Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone. J Pharmacol Exp Therap 281:566-573.
21. Allen, T.M., McAllister, L., Mausolf, S., and Gyorffy, E. 1981. Liposome-cell interactions. A study of the interactions of liposomes containing entrapped anti-cancer drugs with the EMT6, S49 and AE1 (transport-deficient) cell lines. Biochim Biophys Acta 643:346-362.
22. Papahadjopoulos, D., Allen, T.M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S.K., Lee, K.D., Woodle, M.C., Lasic, D.D., Redemann, C., and Martin, F.J. 1991. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA. 88:11460-11464.
23. Suzuki, S., Watanabe, S., Uno, S., Tanaka, M., Masuko, T., and Hashimoto, Y. 1994. Endocytosis does not necessarily augment the cytotoxicity of adriamycin encapsulated in immunoliposomes Biochim Biophys Acta 1224:445-453..
24. Northfelt, D.W., Martin, F.J., Working, P., Volberding, P. A., Russell, J., Newman, M., Amantea, M.A., and Kaplan, L. D. 1996. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumour localization, and safety in patients with AIDS-related Kaposi's sarcoma. JClin Pharmacol. 36:55-63.
25. Wu, N.Z., Braun, R.D., Gaber, M.H., Lim, G.M., Ong, E. T., Shan, S., Papahadjopoulos, D., and Dewhirst, M.W. 1997. Simultaneous measurement of liposome extravasation and content release in tumors. Mircocirculation. 4:83-101.
26. Vaage, J., Donovan, D., Working, P., and Uster, P. Cellular distribution of Doxil® within selected tissues, assessed by confocal laser scanning microscopy. In Medical Applications of Liposomes. D.D. Lasic and D. Papahadjopoulos (eds.), pp. 275-282, Elsevier, Amsterdam. 1998.
27. Truneh, A., Mishal, Z., Barbet, J., Machy, P., and Leserman, L.D. 1983. Endocytosis of liposomes bound to cell surface proteins measured by flow cytofluorometry. Biochem J 214:189-194.
28. De Kruif, J., Storm, G., Vanbloois, L., and Logtenberg, T. 1996. Biosynthetically lipid modified human scFv fragments from phage display libraries as targeting molecules for immunoliposomes. FEBS Lett. 399:232-236.
29. Huang, A., Kennel, S.J., and Huang, L. 1983. Interactions of immunoliposomes with target cells. J Biol Chem 258:14034-14040.
30. Longman, S.A., Cullis, P.R., Choi, L., de Jong, G., and Bally, M.B. 1995. A two-step targeting approach for delivery of doxorubicin-loaded liposomes to tumour cells in vivo. Cancer Chemother Pharmacol. 36:91-101.
31. Szczepek, A.J., Seeberger, K., Wizniak, J., Mant, M.J., Belch, A.R., and Pilarski, L.M. 1998. A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangments with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction. Blood 92:2844-55.
32. Drobyski, M.R. and Hessner, M.J. 1998. The use of the polymerase chain reaction to predict for subsequent relapse in unrelated marrow transplantation for chronic myelogenous leukemia. Leuk Lymphoma. 3:317-23.
33. Vitetta, E.S. and Uhr, J.W. 1994. Monoclonal antibodies as agonists: an expanded role for their use in cancer therapy. Cancer Res. 54:5301-5309..
34. Park, J.W., Hong, K., Kirpotin, D.B., Papahadjopoulos, D., and Benz, C.C. 1997. Immunoliposomes for cancer treatment. Adv Pharmacol. 40:399-435.
35. Waldmann, T.A. 1992. Immune receptors: targets for therapy of leukemia/ lymphoma, autoimmune diseases and for the prevention of allograft rejection. Ann. Rev. Immunol. 10:675-704.
36. Hakomori, S. 1985. Aberrant glycosylation on cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res. 45:2405-2414.
37. de Rie, M.A., Schumacher, T.N., van Schijndel, G.M., van Lier, R.A., and Miedema, F. 1989. Regulatory role of CD19 molecules in B-cell activation and differentiation. Cell Immunol 118: 368-381.
38. Uckun, F.M., Jaszcz, W., Ambrus, J.L., Fauci, A.S., Gajl-Peczalska, K., Song, S.W., Wick, M.R., Myers, D.E., Waddick, K., and Ledbetter, J. 1988. A. Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins. Blood 71:13-29.
39. van Oosterhout, Y.V. J.M., van den Herik-Oudijk, I.E., Wessels, H.M.C., de Witte, T., van de Winkel, J.G.J., and Preijers, F.W.M.B. 1994. Effect of isotype on internalization and cytotoxicity of CD19-ricin A immunotoxins Cancer Res. 54:3527-3532.
40. Press, O.W., Farr, A.G., Borroz, K.I., Andersen, S.K., and Martin, P.J. 1989. Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies. Cancer Res. 49: 4906-4912.
41. Allen, T.M., Hansen, C.B., Martin, F., Redemann, C., and Yau-Young, A. 1991. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta. 1066:29-36.
42. Zalipsky, S. 1993. Synthesis of end-group functionalized polyethylene glycol-lipid conjugates for preparation of polymer-grafted liposomes. Bioconjugate Chem. 4: 296-299.
43. Zola, H., Macardle, P.J., Bradford, T., Weedon, H., Yasui, H., and Kurosawa, Y. 1991. Preparation and characterization of a chimeric CD19 monoclonal antibody. Immunol and Cell Biol. 69:411-422.
44. Pool, G.L., French, M.E., Edwards, R.A., Huang, L., and Lumb, R.H. 1982. Use of radiolabelled hexadecyl cholesterol ether as a liposome marker, Lipids. 17:445-452.
45. Derksen, J.T., Morselt, H.W., and Scherphof, G.L. 1987. Processing of different liposomal markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages. Biochim Biophys Acta. 931:33-40.
46. Mayer, L.D., Hope, M.J., and Cullis, P.R. 1987. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim Biophys Acta. 858:161-168.
47. Bartlett, G.R. 1959. Phosphorus assay in column chromatography. J BiolChem. 234: 466-468.
48. Bolotin, E.M., Cohen, R., Bar, L.K., Emanuel, S.N., Lasic, D.D., and Barenholz, Y. 1994. Ammonium sulphate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandosomes. J Liposome Res. 4:455-479.
49. Hansen, C.B., Kao, G.Y., Moase, E.H., Zalipsky, S., and Allen, T.M. 1995. Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. Biochim Biophys Acta. 1239:133-144.
50. Zalipsky, S., Hansen, C.B., Lopes de Menezes, D.E., and Allen, T.M. 1996. Long-circulating polyethylene glycol-grafted immunoliposomes. J Control Rel. 39:153-161.
51. Kirpotin, D., Park, J.W., Hong, K., Zalipsky, S., Li, W.-L., Carter, P., Benz, C.C., and Papahadjopoulos, D. 1997. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. Biochemistry. 36:66-75.
52. Forssen, E.A., Male-Brune, R., Adler-Moore, J.P., Lee, M. J.A., Schmidt, P.G., Kraieva, T.B., Shimizu, S., and Tromberg, B.J. 1996. Fluorescence imaging studies for the disposition of daunorubicin liposomes (DaunoXome) in tumor tissue. Cancer Res. 56:2066-2075.
53. Daleke, D.L., Hong, K., and Papahadjopoulos, D. 1990. Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay. Biochim Biophys Acta. 1024:352-366.
54. Straubinger, R.M., Papahadjopoulos, D., and Hong, K. 1990. Endocytosis and intracellular fate of liposomes using pyranine as a probe. Biochem. 29:4929-4939.
55. Andersen, A., Warren, D.J., and Slørdal, L. 1993. A sensitive and simple high-performance liquid chromatographic method for the determination of doxorubicin and its metabolite in plasma. Ther. Drug Monit. 15:455-461.
56. Zhang, Y., Sweet, K.M., Sognier, M.A., and Belli, J.A. 1992. An enhanced ability for transforming adriamycin into a non-cytotoxic form in a multidrug-resistant cell line (LZ-8). Biochem Pharmacol. 44:1869-1877.
57. Gabizon, A.A., Barenholz, Y., and Bialer, M. 1993. Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. Pharm. Res. 10:703-708.
58. Beaumelle, B.D. and Hopkins, C. R. 1989. High-yield isolation of functionally competent endosomes from mouse lymphocytes. Biochem. J. 264:137-149.
59. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protien-dye binding. Anal. Biochem. 72:248-254.
60. De Duve, C. and Appelmans, F. 1955. Tissue fractionation studies 3. Further observations of the binding of acid phosphatase by rat-liver particles. Biochem. J. 59: 426-433.
61. Barret, A.J. and Heath, M.F. Lysosomal enzymes. Elsevier/North Holland Biomedical Press, Amsterdam. 1977.
62. Pennington, R.J. 1961. Biochemistry of dystrophic muscle. Biochem. J. 80:361-370.
63. Sottocasa, G.L., Kuylenstierna, B., Ernster, L., and Bergstrand, A. 1967. An electron-transport system associated with the outer membrane of liver mitochondria. J. Cell Biol. 32:415-438.
64. Beaumelle, B.D., Gibson, A., and Hopkins, C.R. 1990. Isolation and preliminary characterization of the major membrane boundaries of the endocytic pathway in lymphocytes. J Cell Biol. 111:1811-1823.
65. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
66. Storm, G., van Bloois, L., Brouwer, M., and Crommelin, D.J. A. 1985. The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposomes preparation. Biochim Biophys Acta. 818:343-351.
67. Amselem, S., Gabizon, A., and Barenholz, Y. 1990. Optimization and upscaling of doxorubicin-containing liposomes for clinical use, J Pharm Sci. 79:1045-1052.
68. Weinstein, J.N., Yoshikami, S., Henkart, P., Blumenthal, R., and Hagins, W. A. 1977. Liposome-cell interaction: transfer and intracellular release of trapped fluorescence marker. Science 195:489-492.
69. Straubinger, R.M., Hong, K., Friend, D.S., and Papahadjopoulos, D. 1983. Endocytosis of liposomes and intracellular fate of encapsulated molecules: encounter with a low pH compartment after internalization in coated vesicles. Cell. 32:1069-1079.
70. Hoekstra, D., Babia, T., Zegers, M., Zaal, K., Arts, E.G.J. M., and Kok, J.W. Dynamic properties of membranes: application of fluorescent lipid analogs In Trafficking of intracellular membranes: from molecular sorting to membrane fusion. M.C. Pedroso De Lima, N. Duzgunes, and D. Hoekstra (eds.), Vol. 91. Springer-Verlag, Berlin. 1995.
71. Brown, V.I. and Greene, M.I. 1991. Molecular and cellular mechanisms of receptor-mediated endocytosis. DNA and Cell Biol. 10:399-409.
72. Mellman, I., Fuchs, R., and Helenius, A. 1986. Acidification of the endocytic and exocytic pathways. Annu Rev Biochem. 55:663-700.
73. Schmid, S.L., Fuchs, R.M., Male, P., and Mellman, I. 1988. Two distinct subpopulations of endosomes involved in membrane recycling and transport to lysosomes. Cell 52:73-83.
74. Renschler, M.F., Wada, H.G., Fok, K.S., and Levy, R. 1995. B-lymphoma cells are activated by peptide ligands of the antigen binding site receptor or by anti-idiotypic antibody to induce extracellular acidification. Cancer Res. 55:5642-47.
75. Pastan, I. and Willingham, M.C. Endocytosis In Endocytosis, I. Pastan and M.C. Willingham (eds.), pp. 1-44. Plenum Press, London, U.K.. 1985.
76. Tjelle, T.E., Brech, A., Juvet, L.K., Griffiths, G., and Berg, T. 1996. Isolation and characterization of early endosomes, late endosomes and terminal lysosomes: their role in protein degradation. J Cell Sci. 109:2905-2914.
77. Gianni, L., Corden, B., and Myers, C. 1983. The biochemical basis of anthracycline toxicity and antitumor action. Rev Biochem Toxicol. 5:1-82.
78. Gigli, M., Doglia, S.M., Millot, J.M., Valentini, L., and Manfait, M. 1988. Quantitative study of doxorubicin in living cell nuclei by microspectrofluorometry. Biochim Biophys Acta. 950:13-20.
79. Arndt-Jovin, D.J. and Jovin, T.M. 1989. Fluorescent labeling and microscopy of DNA. Meth Cell Biol. 30:417-448.
80. Lloyd, J.B. Metabolic efflux and influx across the lysosome membrane. In Subcellular Biochemistry: Biology of the lysosome. J. B. Lloyd and F. Mason (eds.), Vol. 27, pp. 361-386. Plenum Press, New York. 1996.
81. Yoshimura, T., Shono, M., Imai, K., and Hong, K. 1995. Kinetic analysis of endocytosis and intracellular fate of liposomes in single macrophages. J Biochem. 117:34-41.
82. Lee, R.J. and Low, P.S. 1997. Folate-targeted liposomes for drug delivery. J Liposome Res. 7:455-466.
83. Duzgunes, N., Straubinger, R.M., Baldwin, P.A., Friend, D. S., and Papahadjopoulos, D. 1985. Proton-induced fusion of oleic acid-phosphatidylethanolamine liposomes: Biochemistry 24:3091-3098.
84. Carson, D.A. and Ribeiro, J.M. 1993. Apoptosis and disease. Lancet 341:1251-1254.
85. Vingerhoeds, M.H., Steerenberg, P.A., Hendriks, J.J.G. W., Kekker, L.C., van Hoesel, Q.G.C.M., Crommelin, D.J. A., and Storm, G. 1996. Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo. Br J Cancer 74:1023-1029.
86. Allen, T.M., Brandeis, E., Hansen, C.B., Kao, G.Y., and Zalipsky, S. 1995. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim Biophys Acta 1237:99-108.